Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
Teva
Daiichi Sankyo
Mallinckrodt
AstraZeneca

Generated: May 24, 2019

DrugPatentWatch Database Preview

CLINDAGEL Drug Profile

« Back to Dashboard

When do Clindagel patents expire, and what generic alternatives are available?

Clindagel is a drug marketed by Precision Dermat and is included in one NDA. There is one patent protecting this drug.

This drug has thirty-four patent family members in twenty-two countries.

The generic ingredient in CLINDAGEL is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.

Drug patent expirations by year for CLINDAGEL
Pharmacology for CLINDAGEL
Synonyms for CLINDAGEL
(2S-trans)-Methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-.alpha.-D-galacto-octopyranoside 2-(dihydrogen phosphate)
[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate
[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-{[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]formamido}propyl]-4,5-dihydroxy-2-(methylsulfanyl)oxan-3-yl]oxyphosphonic acid
24729-96-2
7(S)-Chloro-7-deoxylincomycin 2-phosphate
AB01566857_01
AC1L9EKE
AKOS008901431
API0002056
AS-12554
AX8019646
BDBM241975
BRD-K27771035-001-02-5
C11728
C18H34ClN2O8PS
CAS-24729-96-2
CHEMBL3184512
Cleocin phosphate
CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Cleocin T
Clinda-Derm
Clindamax
Clindamycin (phosphate)
Clindamycin 2-dihydrogen phosphate
Clindamycin 2-phosphate
Clindamycin dihydrogenphosphat
Clindamycin injection
Clindamycin phosphate
Clindamycin phosphate (JP17/USP)
Clindamycin phosphate [USAN:JAN]
Clindamycin phosphate [USAN:USP:JAN]
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Clindamycin-2-dihydrogenphosphat
CLINDAMYCIN-2-PHOSPHATE
Clindesse
Clindets
CS-4620
D01073
Dalacin P
Dalacin T
Dalacin-S (TN)
DSSTox_CID_28603
DSSTox_GSID_48677
DSSTox_RID_82873
DTXSID1048677
EH6D7113I8
EINECS 246-433-0
Evoclin (TN)
HY-B1064
L-threo-alpha-D-galacto-Octapyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-
L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-
LS-98133
Methyl (2S-trans)-7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-L-threo-alpha-D-galacto-octopyranoside, 2-(dihydrogen phosphate)
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2- pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-(dihydrogen phosphate)
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-(dihydrogen phosphate)
MFCD07793328
MolPort-015-163-859
NCGC00163494-01
NCGC00166320-01
NCGC00386379-01
PubChem5913
s2048
SCHEMBL37148
SR-01000872581
SR-01000872581-1
ST24046358
Tox21_113055
Tox21_113410
U 28508
U-28,508
U-28508
UFUVLHLTWXBHGZ-MGZQPHGTSA-N
UNII-EH6D7113I8
ZINC4102185

US Patents and Regulatory Information for CLINDAGEL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Precision Dermat CLINDAGEL clindamycin phosphate GEL;TOPICAL 050782-001 Nov 27, 2000 BT RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for CLINDAGEL

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1304992 C01304992/01 Switzerland ➤ Sign Up PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
1304992 PA2013025,C1304992 Lithuania ➤ Sign Up PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
1304992 2013C/060 Belgium ➤ Sign Up PRODUCT NAME: CLINDAMYCINE (ALS CLINDAMYCINE FOSFAAT) EN TRETINOINE; AUTHORISATION NUMBER AND DATE: BE437507 20130506
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Julphar
QuintilesIMS
Teva
Medtronic
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.